Make Your Case to Attend the Muscular Disorders Drug Development Summit
Attending the Muscular Disorders Drug Development Summit is an opportunity to stay ahead of the rapidly evolving muscle disease therapeutics landscape, gain practical insights from industry leaders, and bring back actionable strategies to strengthen your organization's translational and clinical development programs.
As the industry's dedicated forum uniting experts advancing therapies across Duchenne muscular dystrophy (DMD), facioscapulohumeral muscular dystrophy (FSHD), myotonic dystrophy (DM1), limb-girdle muscular dystrophy (LGMD), Pompe disease and related myopathies, this summit brings together the community driving the next generation of genetic, stem cell, small molecule and RNA-based therapies.
Whether your focus is discovery research, translational science, biomarker development, clinical operations, regulatory strategy, medical affairs or R&D leadership, this meeting delivers insights that can directly support your team's objectives.
Why This Meeting Matters to Your Organization
Accelerate Translational & Clinical Development
Gain practical insights into preclinical translatability, clinical trial design, endpoint selection and patient stratification strategies to help de-risk development programs and improve clinical success.
Stay Ahead of Cross-Modality Innovation
Explore advances across gene therapies, RNA therapeutics, stem cell approaches and small molecules, while understanding how developers are navigating the evolving muscular disease landscape.
Benchmark Emerging Delivery & Biomarker Strategies
Learn how industry leaders are improving muscle-specific delivery, minimizing off-target effects, and advancing novel biomarkers to better evaluate treatment response and disease progression.
Learn from Recent Industry Progress
Discover lessons learned from approved products, late-stage development programs and upcoming regulatory milestones shaping the future of muscular disorder drug development.
Expand Your Industry Network
Connect with senior leaders spanning pharma, biotech, academia and technology providers working to accelerate transformative therapies for patients with muscular disorders.
Attending Companies Include
Making Approval Easy
Simply download the example approval letter, personalize a few details, and send it directly to your manager, supervisor or department head. We've done the hard work for you, making it easier to demonstrate the tangible value of attendance and explain how the insights gained can support your organization's scientific, clinical and strategic objectives.
Need Additional Help Building Your Case?
If you require further information to support your approval request, we're happy to provide:
- Agenda recommendations tailored to your team and role
- Speaker and attendee insights
- Audience demographics
- Registration and pricing information
- A personalized ROI discussion
Explore the Agenda
Discover exactly how industry leaders are facing the most important development challenges – from targeted muscle delivery, patient pool selection and preclinical model translatability.
Partner With Us
Position your solutions in front of decision-makers actively looking to optimize their muscular disorder drug development, to become a trusted partner and build lasting relationships to support long term success.
Join Biopharma Leaders
Connect with the Muscular Disorder community and be part of the hottest conversations with like-minded attendees and gain access to insights only shared in our innovative face-to face networking sessions.